Effect of Mulligan's Mobilization on Shoulder Joint Range of Motion and Subacromial Space in Paraplegic Patients

NCT ID: NCT06708962

Last Updated: 2025-02-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-12-01

Study Completion Date

2025-02-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the study is to determine the effect of mulligan's mobilization on shoulder range of motion and subacromial joint space in paraplegic patients with subacromial impingement so, thirty patients will be randomly assigned to two groups group (A) and Group (B)

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

30 patients will be randomly assigned to two groups Group (A): will receive Mulligan's mobilization plus steroid injection for rotator cuff tendinopathy Group (B): will receive Steroid injection for rotator cuff tendinopathy only

Outcome measures will be:

* shoulder joint range of motion will be measured by laser goniometer
* Subacromial joint space will be measured by 3D ultrasonography

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Paraplegia, Incomplete

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Randomized controlled trial
Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group A

Will receive mulligan's mobilization plus corticosteroid injection for shoulder joint

Group Type ACTIVE_COMPARATOR

Mulligan's mobilization

Intervention Type OTHER

Mulligan mobilization isthe concurrent application of sustained accessory mobilization applied by a therapist and an active physiological movement to end range applied by the patient.

corticosteroid injection for rotator cuff tendinopathy

Intervention Type OTHER

corticosteroid injection for rotator cuff helps resolving inflammation which occur for paraplegic patients from overuse of the crutches

corticosteroid injection for rotator cuff tendinopathy only

patients will receive corticosteroid injection for rotator cuff muscle only which helps in resolving inflammation at the shoulder joint

Group Type SHAM_COMPARATOR

corticosteroid injection for rotator cuff tendinopathy

Intervention Type OTHER

corticosteroid injection for rotator cuff helps resolving inflammation which occur for paraplegic patients from overuse of the crutches

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Mulligan's mobilization

Mulligan mobilization isthe concurrent application of sustained accessory mobilization applied by a therapist and an active physiological movement to end range applied by the patient.

Intervention Type OTHER

corticosteroid injection for rotator cuff tendinopathy

corticosteroid injection for rotator cuff helps resolving inflammation which occur for paraplegic patients from overuse of the crutches

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* More than one year after traumatic spinal cord injury
* The injury is at the second thoracic level or below.
* No cognitive impairment
* Relying on manual wheelchair for main movement.

Exclusion Criteria

* No frozen shoulder
* No subluxation
Minimum Eligible Age

40 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

MTI University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Radwa Fayek Hammam

Lecturer at Basic Science Department

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Modern University for Technology and Information

Cairo, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Related Links

Access external resources that provide additional context or updates about the study.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

P.T.REC/012/003273

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Scapular Mobilization Versus Capsular Stretch
NCT06705426 NOT_YET_RECRUITING NA